Mitomycin derivatives having unique condensed-ring structures. Their synthesis and antitumor activity.
A series of mitomycin derivatives 1-3 having unique condensed-ring structures was synthesized and evaluated for their anticellular and antitumor activity. These compounds were synthesized by the Michael addition of 1.3-dicarbonyl compounds to 6-demethyl-7,7-(ethylenedioxy)-6,7-dihydro-6-methylenemitosanes (4-6, and 14) and the subsequent cyclization. For the preparation of 1. the allyloxycarbonyl (Aloc) group was employable for the protection of the aziridine (1a-N-H), since the deprotection proceeded without decomposition of the substrates under the mild conditions with Pd(0) and HCO2H-NEt3. Among these structurally unique derivatives, compounds 1a, 1b, 1d and 1e were quite potent against HeLa S3 human tumor cells and sarcoma 180 solid tumor in mice.
Arai
H
H
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.
Kanda
Y
Y
Ashizawa
T
T
Morimoto
M
M
Gomi
K
K
Kono
M
M
Kasai
M
M
D000818:Animals; D006367:HeLa Cells / Q000187:drug effects; D006801:Humans; D051379:Mice; D008937:Mitomycins / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D012510:Sarcoma 180 / Q000188:drug therapy
D008937:Mitomycins